Fdanewsdrugdailybulletin

March 24, 2017

Vol. 14 No. 57

View Archived Issues

Sign Up Now

EU Court Maintains Suspension of EMA Document Release

Companies filed suit seeking to block the EMA’s release of industry documents requested by third parties.  Read More

Four Former FDA Commissioners Advise Against Drug Importation

Commissioners argued imported drugs could be substandard, adulterated or fake. Read More

Valeant Sues Teva Over Onexton Generics

The patents in dispute expire in 2029. Read More

Maryland House Passes Drug Price-Gouging Bill

The bill would ban price gouging of essential generic medicines. Read More

Newron’s Xadago Nets FDA Approval to Treat Parkinson’s Disease as Add-on Therapy

The studies found patients reported better motor functions when using Xadago. Read More